VF
DAWN

Virtu Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Virtu Financial’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,941
Closed -$146K – 1613
2023
Q1 		$146K Buy
+10,941
New +$214K 0.02% 848
2021
Q3 		– Sell
-12,497
Closed -$285K – 1596
2021
Q2 		$285K Buy
+12,497
New +$261K 0.03% 754

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Virtu Financial's DAWN Position: Q2 2023 in Review

Virtu Financial sold out of Day One Biopharmaceuticals (DAWN) in Q2 2023, closing a stake of 10,941 shares — an estimated $146K sold.

Virtu Financial first reported a position in DAWN in Q2 2021 and held it in 2 quarters. The position peaked at $285K in Q2 2021. 140 funds tracked by Wall St. Rank hold DAWN as of Q2 2023.

  • Virtu Financial reported no remaining Day One Biopharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 10,941 Day One Biopharmaceuticals shares in Q2 2023, an estimated $146K.
  • Virtu Financial first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Virtu Financial's Day One Biopharmaceuticals position peaked at $285K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.